(TIC) Acuren - Overview
Stock: Inspection, Testing, Certification, Rope-Access, Engineering
| Risk 5d forecast | |
|---|---|
| Volatility | 62.3% |
| Relative Tail Risk | 1.05% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.27 |
| Alpha | -35.47 |
| Character TTM | |
|---|---|
| Beta | 0.948 |
| Beta Downside | 1.072 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.10% |
| CAGR/Max DD | -0.55 |
Description: TIC Acuren January 16, 2026
TIC Solutions, Inc. (NYSE:TIC) is a U.S.-based provider of critical asset-integrity services, formerly known as Acuren Corporation until its rebranding in October 2025. Founded in 1974 and headquartered in Hollywood, Florida, the firm operates across the GICS sub-industry of Research & Consulting Services, delivering testing, inspection, certification, and compliance (TICC) solutions to a broad industrial client base.
The company’s portfolio spans nondestructive testing (radiography, ultrasonic, magnetic-particle, penetrant, and visual inspection), market rope-access services, coatings, welding, pipe-fitting, rigging, and electrical work, as well as consulting engineering support for destructive testing, failure investigation, corrosion and welding engineering, fracture mechanics, and chemical analysis. In FY 2024, TIC reported approximately $475 million in revenue with a 12% operating margin and a backlog of $210 million, reflecting steady demand from sectors such as chemicals, pipelines, refineries, power generation, oil-sand operations, and emerging renewable-energy infrastructure. The global NDT market is projected to grow at a CAGR of 6-7% through 2030, driven by tighter safety regulations, aging energy assets, and increased capital spending on clean-energy transitions-key tailwinds for TIC’s service lines.
For a data-driven deep-dive into TIC’s valuation metrics and scenario analysis, a quick look at ValueRay’s platform can provide the quantitative context you need.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: -68.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -3.15 > 1.0 |
| NWC/Revenue: 36.05% < 20% (prev 29.42%; Δ 6.63% < -1%) |
| CFO/TA 0.01 > 3% & CFO 51.8m > Net Income -68.5m |
| Net Debt (1.55b) to EBITDA (133.2m): 11.64 < 3 |
| Current Ratio: 2.41 > 1.5 & < 3 |
| Outstanding Shares: last quarter (122.5m) vs 12m ago 0.88% < -2% |
| Gross Margin: 25.31% > 18% (prev 0.23%; Δ 2508 % > 0.5%) |
| Asset Turnover: 39.22% > 50% (prev 45.10%; Δ -5.89% > 0%) |
| Interest Coverage Ratio: 0.11 > 6 (EBITDA TTM 133.2m / Interest Expense TTM 58.0m) |
Altman Z'' 0.55
| A: 0.11 (Total Current Assets 791.9m - Total Current Liabilities 329.0m) / Total Assets 4.22b |
| B: -0.03 (Retained Earnings -146.9m / Total Assets 4.22b) |
| C: 0.00 (EBIT TTM 6.15m / Avg Total Assets 3.27b) |
| D: -0.07 (Book Value of Equity -149.6m / Total Liabilities 2.27b) |
| Altman-Z'' Score: 0.55 = B |
Beneish M -2.43
| DSRI: 1.70 (Receivables 577.6m/278.2m, Revenue 1.28b/1.05b) |
| GMI: 0.90 (GM 25.31% / 22.81%) |
| AQI: 0.97 (AQ_t 0.74 / AQ_t-1 0.76) |
| SGI: 1.22 (Revenue 1.28b / 1.05b) |
| TATA: -0.03 (NI -68.5m - CFO 51.8m) / TA 4.22b) |
| Beneish M-Score: -2.43 (Cap -4..+1) = BBB |
What is the price of TIC shares?
Over the past week, the price has changed by -5.45%, over one month by -9.13%, over three months by -14.35% and over the past year by -20.42%.
Is TIC a buy, sell or hold?
- StrongBuy: 0
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TIC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14.3 | 49.2% |
| Analysts Target Price | 14.3 | 49.2% |
| ValueRay Target Price | 9.5 | -0.9% |
TIC Fundamental Data Overview February 04, 2026
P/S = 1.7021
P/B = 1.1771
Revenue TTM = 1.28b USD
EBIT TTM = 6.15m USD
EBITDA TTM = 133.2m USD
Long Term Debt = 1.59b USD (from longTermDebt, last quarter)
Short Term Debt = 57.4m USD (from shortTermDebt, last quarter)
Debt = 1.72b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.55b USD (from netDebt column, last quarter)
Enterprise Value = 3.74b USD (2.19b + Debt 1.72b - CCE 164.4m)
Interest Coverage Ratio = 0.11 (Ebit TTM 6.15m / Interest Expense TTM 58.0m)
EV/FCF = 1000.0x (Enterprise Value 3.74b / FCF TTM 530.9k)
FCF Yield = 0.01% (FCF TTM 530.9k / Enterprise Value 3.74b)
FCF Margin = 0.04% (FCF TTM 530.9k / Revenue TTM 1.28b)
Net Margin = -5.33% (Net Income TTM -68.5m / Revenue TTM 1.28b)
Gross Margin = 25.31% ((Revenue TTM 1.28b - Cost of Revenue TTM 959.1m) / Revenue TTM)
Gross Margin QoQ = 32.23% (prev 23.60%)
Tobins Q-Ratio = 0.89 (Enterprise Value 3.74b / Total Assets 4.22b)
Interest Expense / Debt = 1.55% (Interest Expense 26.5m / Debt 1.72b)
Taxrate = 21.0% (US default 21%)
NOPAT = 4.86m (EBIT 6.15m * (1 - 21.00%))
Current Ratio = 2.41 (Total Current Assets 791.9m / Total Current Liabilities 329.0m)
Debt / Equity = 0.88 (Debt 1.72b / totalStockholderEquity, last quarter 1.95b)
Debt / EBITDA = 11.64 (Net Debt 1.55b / EBITDA 133.2m)
Debt / FCF = 2921 (out of range, set to none) (Net Debt 1.55b / FCF TTM 530.9k)
Total Stockholder Equity = 1.35b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.09% (Net Income -68.5m / Total Assets 4.22b)
RoE = -5.06% (Net Income TTM -68.5m / Total Stockholder Equity 1.35b)
RoCE = 0.21% (EBIT 6.15m / Capital Employed (Equity 1.35b + L.T.Debt 1.59b))
RoIC = 0.21% (NOPAT 4.86m / Invested Capital 2.32b)
WACC = 5.81% (E(2.19b)/V(3.90b) * Re(9.41%) + D(1.72b)/V(3.90b) * Rd(1.55%) * (1-Tc(0.21)))
Discount Rate = 9.41% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 50.64%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈29.8m ; Y1≈19.6m ; Y5≈8.92m
Fair Price DCF = N/A (negative equity: EV 284.3m - Net Debt 1.55b = -1.27b; debt exceeds intrinsic value)
EPS Correlation: 63.11 | EPS CAGR: 10.3k% | SUE: N/A | # QB: 0
Revenue Correlation: 62.77 | Revenue CAGR: 56.40% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.01 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=0.39 | Chg30d=+0.058 | Revisions Net=+0 | Growth EPS=+55.9% | Growth Revenue=+43.7%